Increased oxidizability of plasma lipoproteins in diabetic patients can be decreased by probucol therapy and is not due to glycation
Alexander V. Babiy*, Janusz M. Gebicki, David R. Sullivan, Karen Willey
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
92
Link opens in a new tab
Citations
(Scopus)